LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey
1 other identifier
observational
2,000
1 country
1
Brief Summary
Cancer survivors face unique health challenges as a result of their cancer diagnosis and treatment. OncoLink created an Internet based program for survivors to learn about their risks. A follow up survey will allow us to continue to develop the program in ways that will benefit users. This survey will need to be conducted via email, which will require the collection of the users email address and a secure method of linking the users care plan questionnaire answers to their survey answers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 19, 2015
CompletedFirst Posted
Study publicly available on registry
September 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedJuly 19, 2022
July 1, 2022
5.6 years
August 19, 2015
July 18, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of subjects completing questionnaires
2 years
Interventions
Eligibility Criteria
Subject with cancer diagnosis
You may qualify if:
- Diagnosis of cancer
- years of age and older
You may not qualify if:
- Persons who have never had cancer. This program is designed for survivors of adult cancers.
- Survivors of childhood cancers are referred to the Children's Oncology Group Long Term Follow up Guidelines.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Metz, MD
Abramson Cancer Center at Penn Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2015
First Posted
September 24, 2015
Study Start
May 1, 2010
Primary Completion
December 1, 2015
Study Completion
July 1, 2016
Last Updated
July 19, 2022
Record last verified: 2022-07